Skip to main content
. 2013 Jan 28;165(2):101–109. doi: 10.1016/j.jconrel.2012.11.002

Fig. 3.

Fig. 3

Analysis of DCs in cervical dLNs 24 h after intradermal injection of pHrodo-labeled neoglycocomplexes vs. unmodified allergens into the mouse ear pinnae. Gating strategy to identify MHC-IIhigh DCs (A), further characterized into CD8α positive and negative DCs (D) as well as quantitation of (here depicted MN–Ova) pHrodo + DCs (B). Percentage of MHC-IIhigh and pHrodo + DCs in dLNs (C). DC subclass distribution of pHrodo + DCs in dLNs (E and F). Data are shown as means ± SEM (n = 3). * P < 0.05; ** P < 0.01.